56136-84-6

Basic information

• Product Name: 4,5-METHYLENEDIOXY-2-NITROACETOPHENONE
• Synonyms: 4,5-METHYLENEDIOXY-2-NITROACETOPHENONE;1-(6-Nitro-1,3-benzodioxol-5-yl)ethanone;1-(6-nitro-1,3-benzodioxol-5-yl)ethan-1-one;5-Acetyl-6-nitro-1,3-benzodioxole;Einecs 260-010-8;1-(5-nitrobenzo[d][1,3]dioxol-6-yl)ethanone;1-(6-nitrobenzo[d][1,3]dioxol-5-yl)ethanone
• CAS NO: 56136-84-6
• Molecular Formula: C₉H₇NO₅
• Molecular Weight: 209.16
• EINECS: 260-010-8
• Mol File: 56136-84-6.mol
• Article Data: 13

Chemical Properties

• Melting Point: 121-123°C
• Boiling Point: 392.4°C at 760 mmHg
• Flash Point: 202.5°C
• Appearance: /
• Density: 1.452g/cm³
• Vapor Pressure: 2.29E-06mmHg at 25°C
• Refractive Index: 1.595
• Storage Temp.: 2-8°C
• Water Solubility: Insoluble in water.
• BRN: 199756
• CAS DataBase Reference: 4,5-METHYLENEDIOXY-2-NITROACETOPHENONE(CAS DataBase Reference)
• NIST Chemistry Reference: 4,5-METHYLENEDIOXY-2-NITROACETOPHENONE(56136-84-6)
• EPA Substance Registry System: 4,5-METHYLENEDIOXY-2-NITROACETOPHENONE(56136-84-6)

Safety Data

• Safety Statements: 22-24/25
• Hazardous Substances Data: 56136-84-6(Hazardous Substances Data)

Usage

Description

4,5-METHYLENEDIOXY-2-NITROACETOPHENONE is an organic compound that serves as a crucial intermediate in various chemical processes and research applications. It is characterized by its unique molecular structure, which features a nitro group and two methoxy groups attached to a benzene ring.

Uses

Used in Organic Syntheses:
4,5-METHYLENEDIOXY-2-NITROACETOPHENONE is used as an intermediate in organic syntheses for the production of various chemical compounds. Its versatile structure allows for further functionalization and modification, making it a valuable building block in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Chemical Research:
In the field of chemical research, 4,5-METHYLENEDIOXY-2-NITROACETOPHENONE is employed as a key compound for studying reaction mechanisms, exploring new synthetic routes, and developing innovative methodologies. Its unique reactivity and structural features make it an attractive candidate for researchers looking to advance the understanding of organic chemistry and its applications.

InChI:InChI=1/C9H7NO5/c1-5(11)6-2-8-9(15-4-14-8)3-7(6)10(12)13/h2-3H,4H2,1H3

Upstream product

• 3162-29-6 1-(benzo[d][1,3]dioxol-6-yl)ethanone 
• 75-24-1 trimethylaluminum 
• 712-97-0 6-nitro-1,3-benzodioxole-5-carbaldehyde 

Downstream Products

• 1551078-87-5 (R,S)-1-bromo-1-[4′,5′-(methylenedioxy)-2′-nitrophenyl]ethane 
• 1450663-81-6 1-(4,5-dihydroxy-2-nitrophenyl)ethanone 
• 1450663-80-5 C₁₈H₁₂N₂O₇ 
• 1450663-82-7 C₁₂H₁₇NO₇ 
• 1293935-95-1 1-(2-bromo-4,6-difluorophenyl)-5-(4,5-methylenedioxy-2-nitrophenyl)pyrazole 
• 1293936-08-9 5-(2-amino-4,5-methylenedioxyphenyl)-1-(2-bromo-5-methylphenyl)pyrazole 
• 1293936-07-8 5-(2-amino-4,5-methylenedioxyphenyl)-1-(2-bromo-4,6-difluorophenyl)pyrazole 
• 1293936-06-7 5-(2-amino-4,5-methylenedioxyphenyl)-1-(2-bromophenyl)pyrazole 
• 76787-36-5 8-<1,3-dioxocyclohex-2-yl)ethyl><1,3>dioxolo<4,5-g>quinoline 
• 182122-16-3 methyl 4-[4-(1-hydroxyethyl)-2-methoxy-5-nitrophenoxy]butyrate 

Relevant articles and documents

MATTER OF COMPOSITION, SYNTHESIS, FORMULATION AND APPLICATION OF FL118 PLATFORM POSITIONS 7 AND 9-DERIVED ANALOGUES FOR TREATMENT OF HUMAN DISEASE

Described herein, are the chemical synthesis, matter of compositions, formulation, function, methods and uses of the FL118 platform Positions 7 and/or 9-derived analogues for treating cancer or other human diseases. Compounds derived from chemical modifications of the FL118 platform are employed alone or in combination with other anti-cancer agents to preclude, eliminate or reverse cancer phenotypes. This invention intends to realize unique personalized cancer treatment (personalized precision medicine) through application of a series of structural relevant individual FL118 platform-derived analogues, which target multiple cellular human disease-relevant proteins and their signaling pathways.

METHODS AND COMPOSITIONS

The invention relates to genetic incorporation of 2,3-diamino propionic acid (DAP) into polypeptides, to unnatural amino acids comprising DAP, to a tRNA synthetase for charging tRNA with unnatural amino acids comprising DAP, and to methods of using the resulting polypeptides, for example in capturing substrates and/or intermediates in enzymatic reactions. The invention also relates to compounds of formula (I) or (II): or salts, solvates, tautomers, isomers or mixtures thereof.

COMPOUND, SUBSTRATE FOR PATTERN FORMATION, PHOTODEGRADABLE COUPLING AGENT, PATTERN FORMATION METHOD, AND TRANSISTOR PRODUCTION METHOD

Provided is a compound represented by Formula (1).